Hydrocodone/Homatropine

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
1
Deaths Reported
830.0%
Death Rate

Active Ingredients

Hydrocodone/Homatropine

Administration Routes

UnknownOral

Species Affected

Dog 12

Most Affected Breeds

Crossbred Canine/dog 6
Maltese 3
Chihuahua 1
Spaniel - King Charles Cavalier 1
Dog (other) 1

Most Reported Reactions

Cough 3
Diarrhoea 2
Vomiting 2
Excessive thirst 2
Frequent urination 2
Tiredness 2
Diabetic ketoacidosis 1
Polydipsia 1
Polyuria 1
Inappetence 1
Lethargy (see also Central nervous system depression in 'Neurological') 1
Diabetic ketonuria 1

Outcome Breakdown

Recovered/Normal
8 (66.7%)
Outcome Unknown
3 (25.0%)
Died
1 (8.3%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 1
Case-fatality rate (reported events) 830.0%
Distinct species in reports 1
Distinct breeds in reports 5
Distinct reactions reported 19
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Hydrocodone/Homatropine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Hydrocodone/Homatropine, including 1 reports in which the animal died — a 830.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Hydrocodone/Homatropine. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Hydrocodone/Homatropine reports are Dog (12 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (6), Maltese (3), Chihuahua (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Hydrocodone/Homatropine are Cough (3), Diarrhoea (2), Vomiting (2), Excessive thirst (2). Of the 12 reports with a coded outcome, Recovered/Normal is the leading category at 66.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Hydrocodone/Homatropine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial